DrugCite
Search

ENDOXAN BAXTER

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Endoxan Baxter Adverse Events Reported to the FDA Over Time

How are Endoxan Baxter adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Endoxan Baxter, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Endoxan Baxter is flagged as the suspect drug causing the adverse event.

Most Common Endoxan Baxter Adverse Events Reported to the FDA

What are the most common Endoxan Baxter adverse events reported to the FDA?

Febrile Neutropenia
39 (2.1%)
Pyrexia
36 (1.94%)
Anaemia
31 (1.67%)
Neutropenia
30 (1.62%)
Dyspnoea
29 (1.56%)
Thrombocytopenia
28 (1.51%)
Sepsis
27 (1.45%)
Septic Shock
27 (1.45%)
Hyperpyrexia
26 (1.4%)
Headache
24 (1.29%)
Interstitial Lung Disease
22 (1.18%)
Show More Show More
Pancytopenia
22 (1.18%)
Condition Aggravated
21 (1.13%)
Vomiting
21 (1.13%)
Cough
18 (.97%)
Diarrhoea
18 (.97%)
Febrile Bone Marrow Aplasia
18 (.97%)
Stomatitis
17 (.92%)
Mucosal Inflammation
15 (.81%)
Nausea
15 (.81%)
Pneumonia
15 (.81%)
Progressive Multifocal Leukoencepha...
15 (.81%)
Bone Sarcoma
14 (.75%)
Asthenia
13 (.7%)
Pulmonary Embolism
13 (.7%)
Bone Marrow Failure
12 (.65%)
Cardiac Failure
12 (.65%)
Renal Failure Acute
12 (.65%)
Bronchopneumonia
11 (.59%)
Hepatic Function Abnormal
11 (.59%)
Hypotension
11 (.59%)
Pleural Effusion
11 (.59%)
Renal Failure
11 (.59%)
White Blood Cell Count Decreased
11 (.59%)
Lung Disorder
10 (.54%)
Lung Infection
10 (.54%)
Renal Impairment
10 (.54%)
Respiratory Failure
10 (.54%)
Atrial Fibrillation
9 (.48%)
Death
9 (.48%)
Dehydration
9 (.48%)
Leukopenia
9 (.48%)
Staphylococcal Sepsis
9 (.48%)
Syncope
9 (.48%)
Ascites
8 (.43%)
Chills
8 (.43%)
Convulsion
8 (.43%)
Cytolytic Hepatitis
8 (.43%)
Gastrointestinal Haemorrhage
8 (.43%)
Herpes Zoster
8 (.43%)
Pulmonary Fibrosis
8 (.43%)
Tachycardia
8 (.43%)
Dysphagia
7 (.38%)
Erythema
7 (.38%)
Gamma-glutamyltransferase Increased
7 (.38%)
Guillain-barre Syndrome
7 (.38%)
Hepatotoxicity
7 (.38%)
Hyponatraemia
7 (.38%)
Infection
7 (.38%)
Pruritus
7 (.38%)
Pulmonary Oedema
7 (.38%)
Stevens-johnson Syndrome
7 (.38%)
Acute Respiratory Distress Syndrome
6 (.32%)
Aspergillosis
6 (.32%)
Autoimmune Hepatitis
6 (.32%)
Cholestasis
6 (.32%)
Cytomegalovirus Infection
6 (.32%)
Dermatitis Bullous
6 (.32%)
Dysuria
6 (.32%)
Fatigue
6 (.32%)
Hepatitis
6 (.32%)
Hepatitis Acute
6 (.32%)
Hypertension
6 (.32%)
Hypoaesthesia
6 (.32%)
Multi-organ Failure
6 (.32%)
Musculoskeletal Pain
6 (.32%)
Oedema Peripheral
6 (.32%)
Purpura
6 (.32%)
Respiratory Distress
6 (.32%)
Rhinorrhoea
6 (.32%)
Sneezing
6 (.32%)
Thrombotic Microangiopathy
6 (.32%)
Tumour Lysis Syndrome
6 (.32%)
Venoocclusive Liver Disease
6 (.32%)
Acute Myeloid Leukaemia
5 (.27%)
Bacterial Sepsis
5 (.27%)
Blood Alkaline Phosphatase Increase...
5 (.27%)
Blood Pressure Decreased
5 (.27%)
Cardiomyopathy
5 (.27%)
Congestive Cardiomyopathy
5 (.27%)
Deep Vein Thrombosis
5 (.27%)
Drug Exposure During Pregnancy
5 (.27%)
Escherichia Sepsis
5 (.27%)
Extravasation
5 (.27%)
Haematemesis
5 (.27%)
Haemorrhage
5 (.27%)
Ileus Paralytic
5 (.27%)
Leukoencephalopathy
5 (.27%)
Liver Disorder
5 (.27%)
Loss Of Consciousness
5 (.27%)
Myelodysplastic Syndrome
5 (.27%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Endoxan Baxter, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Endoxan Baxter is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Endoxan Baxter

What are the most common Endoxan Baxter adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Endoxan Baxter, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Endoxan Baxter is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Endoxan Baxter According to Those Reporting Adverse Events

Why are people taking Endoxan Baxter, according to those reporting adverse events to the FDA?

Breast Cancer
74
Non-hodgkins Lymphoma
51
Chronic Lymphocytic Leukaemia
40
Drug Use For Unknown Indication
33
B-cell Lymphoma
23
Lymphoma
22
Show More Show More
Off Label Use
21
Acute Lymphocytic Leukaemia
20
Diffuse Large B-cell Lymphoma
20
Multiple Myeloma
18
Systemic Lupus Erythematosus
16
Bone Marrow Conditioning Regimen
8
Multiple Sclerosis
8
Burkitts Lymphoma
8
Primary Mediastinal Large B-cell Ly...
7
Microscopic Polyangiitis
7
Vasculitis
6
Acute Myeloid Leukaemia
6
Waldenstroms Macroglobulinaemia
6
Lupus Nephritis
6
Medulloblastoma
5
T-cell Prolymphocytic Leukaemia
5
Chemotherapy
5
Rheumatoid Arthritis
5
Immunosuppression
4
Acquired Haemophilia
4
Mantle Cell Lymphoma
4
Suicide Attempt
4
T-cell Lymphoma
4
Bone Sarcoma
4
Rhabdomyosarcoma
4
Breast Cancer Female
4
Chloroma
4
Anaplastic Large Cell Lymphoma T- A...
3
Polyneuropathy
3
Bone Marrow Transplant
3
Wegeners Granulomatosis
3
Interstitial Lung Disease
3
Lymphocytic Lymphoma
3
High Grade B-cell Lymphoma Burkitt-...
3
Neuroblastoma
3
Hodgkins Disease
3
Connective Tissue Disorder
3
Disseminated Large Cell Lymphoma
3
Vasculitis Cerebral
3
Iga Nephropathy
3
Breast Cancer Recurrent
3
Product Used For Unknown Indication
3
Non-hodgkins Lymphoma Stage Iv
3
Glomerulonephritis
3
Breast Cancer Metastatic
3

Endoxan Baxter Case Reports

What Endoxan Baxter safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Endoxan Baxter. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Endoxan Baxter.